Fig. 3

WPAI-SHP scores among currently employed respondents. ET, essential thrombocythemia; MF, myelofibrosis; MPN, myeloproliferative neoplasm; PV, polycythemia vera; RA, rheumatoid arthritis; WPAI-SHP, Work Productivity and Activity Impairment Specific Health Problem questionnaire. All items based on 7-day recall (ie, regarding work/activity during the 7 days preceding the survey). *Ranges for published data include scores at baseline and after active treatment for RA in studies of European patients with moderate RA (Pavelka et al. 2013 [15]) and patients from the United States with moderate to severe RA (Hone et al. 2013 [13])